Abstract
The Perceval S bioprosthesis (21 and 23 mm) was approved for clinical use in December 2010 and it is now routinely used. This bioprosthesis is suggested for the treatment of patients undergoing minimally-invasive surgery for reasons of safety and reduction in implantation time. Here we describe the use of the Perceval bioprosthesis in patients undergoing minimally invasive cardiac surgery.
MeSH terms
-
Aortic Valve / diagnostic imaging
-
Aortic Valve / surgery*
-
Aortic Valve Stenosis / diagnostic imaging
-
Aortic Valve Stenosis / surgery*
-
Bioprosthesis*
-
Echocardiography, Transesophageal
-
Follow-Up Studies
-
Heart Valve Prosthesis Implantation / methods*
-
Heart Valve Prosthesis*
-
Humans
-
Minimally Invasive Surgical Procedures / methods*
-
Prosthesis Design
-
Retrospective Studies
-
Suture Techniques*
-
Treatment Outcome